Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases Units
This study demonstrates that most Infectious Diseases Units in Italy continue to consider GRT an essential test for newly diagnosed people living with HIV in clinical practice. However, the utilization of GRT on HIV-DNA remains limited. Further efforts are required to decrease turnaround time in centres experiencing prolonged delays in obtaining results.
Authors
- Gian Luca Valenti
- Sergio Malandrin
- Andrea De Vito (ORCID: https://orcid.org/0000-0002-8265-5400)
- Luna Colagrossi (ORCID: https://orcid.org/0000-0001-5618-1523)
- Alessandro Cozzi‐Lepri (ORCID: https://orcid.org/0000-0002-6339-919X)
- Stefano Rusconi (ORCID: https://orcid.org/0000-0002-0375-9990)
- Antonia Bezenchek
- Rossana Scutari (ORCID: https://orcid.org/0000-0001-8549-9645)
- Ludovico Pipitò (ORCID: https://orcid.org/0000-0002-1824-7541)
- Francesca Ceccherini‐Silberstein (ORCID: https://orcid.org/0000-0002-6024-5101)
- M. Tallarita
- Sergio Lo Caputo (ORCID: https://orcid.org/0000-0002-4729-7548)
- Maria Concetta Bellocchi (ORCID: https://orcid.org/0000-0001-7717-2343)
- S Ferrara
Institutions
- University of Foggia (IT)
- University of Rome Tor Vergata (IT)
- University of Sassari (IT)
- National Institute for Health and Care Research (GB)
- Informa (Italy) (IT)
- Department of Health (ES)
- Azienda Ospedaliera San Gerardo (IT)
- Bambino Gesù Children's Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Azienda Ospedaliera Ospedale Civile di Legnano (IT)
- University College London (GB)
- University of Palermo (IT)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1016/j.jgar.2025.01.018
- Citations
- 2
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.79